Antimicrobial resistance of Streptococcus pneumoniae strains isolated in the Reunion Island during 2004;Résistance aux antibiotiques de Streptococcus pneumoniae à la Réunion en 2004

Medecine et Maladies Infectieuses

Volumn 36, Issue 1, 2006, Pages 47-51

  Simac, C ^a   Picot, S ^a   Farny, K ^a   Michault, A ^a  

^a Groupe Hospitalier Sud Reunion   (France)

Author keywords

Antimicrobial resistance; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; PRISTINAMYCIN; RIFAMPICIN; TELITHROMYCIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DRUG SENSITIVITY; HUMAN; REUNION; STREPTOCOCCUS PNEUMONIAE;

AZA COMPOUNDS; BETA-LACTAMS; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CHLORAMPHENICOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; KETOLIDES; PENICILLIN RESISTANCE; QUINOLINES; RETROSPECTIVE STUDIES; REUNION; RIFAMPIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TETRACYCLINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 31944440063     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.09.007     Document Type: Article

References (22)

1. N. Morton Bacterial meningitis - a view of the past 90:years N. Engl. J. Med. 351 2004 1826 1828
2. D. Hansman, and M.M. Bullen A resistant pneumococcus Lancet 2 1967 264 265
3. P.C. Appelbaum Resistance among Streptococcus:pneumoniae: Implications for drug selection Clin. Infect. Dis. 34 2002 1613 1620
4. D. Felmingham The need for antimicrobial resistance surveillance J. Antimicrob. Chemother 50 Suppl S1 2002 1 7
5. A. Michault, and C. Simac Donńes bact́riologiques et ́pid́miologiques pour Streptococcus:pneumoniae ̀ l'hôpital Sud de La Ŕunion Bull. Soc. Pathol. Exot. 93 4 2000 281 286
6. Société Française de Microbiologie. Comité de l'antibiogramme de la Société française de microbiologie. Communiqué 2004. htp://www.sfm.asso.fr.
7. M.C. Demachy, F. Faibis, A. Artigon, C. Benoit, E. Cambau, and A. Cecille Épid́mie et ŕsistance aux antibiotiques de Streptococcus:pneumoniae Med. Mal. Infect. 34 2004 303 309
8. M. Vergnaud, S. Bourdon, M. Brun, B. Cattier, C. Chanal, and H. Chardon Observatoires ŕgionaux du pneumocoque:: analyse de la ŕsistance aux antibiotiques et des śrotypes de Streptococcus:pneumoniae en 2001 BEH 37 2003 173 176
9. European antimicrobial resistance surveillance system (EARSS). Annual report 2001; 27-38. http.//www.earss.rivm.nl/PAGINA/DOC/report 2001.pdf.
10. J. Dellamonica, P. Follana, A. Michault, C. Arvin-Berod, H. Carsenti-Etesse, and B. Dunais Portage nasopharynǵ de Streptococcus:pneumoniae (SP) chez les enfants fŕquentant les cr̀ches de l'Île-de-la-Ŕunion 1999 RICAI Île-de-la- Ŕunion
11. J.P. Bedos, E. Valĺe, B. Veber, E. Azoulay-Dupuis, and J.J. Pocidalo Immunod́pression et infections pneumococciques «:Infection ̀ pneumocoque de sensibilit́ diminúe aux b̂talactamine: » 1993 Spinger-Verlag France Paris
12. K.P. Klugman Pneumococcal resistance to antibiotics Clin. Microb. Rev. 3 1990 171 196
13. R. Pallares, P.F. Viladrich, J. Linares, C. Cabellos, and F. Gudiol Impact of antibiotic resistance on chemotherapy for pneumococcal infections Microb. Drug Resist. 4 1998 339 347
14. J.P. Metlay, J. Hofina, M.S. Cetron, M.J. Fine, M.M. Farley, and C. Withney Impact of penicillin susceptibility on medical outcomes for adult patient with bacteremic pneumococcal pneumonia Clin. Infect. Dis. 30 2000 520 528
15. D.J. Farell, and D. Felmingham Activities of telithromycin against 13.874 Streptococcus:pneumoniae isolates collected between 1999 and 2003 Antimicrob. Agents Chemother. 48 2004 1882 1884
16. M.I. Morosini, R. Canton, E. Loza, M.C. Negri, J.C. Galan, and F. Almaraz In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms Antimicrob. Agents Chemother. 45 2001 2427 2431
17. K. Nagai, P.C. Appelbaum, T.A. Davies, L.M. Kelly, D.B. Hoellman, and A.T. Andrasevic Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 central and eastern European countries Antimicrob. Agents Chemother. 46 2002 371 377
18. P.S. Meier, S. Utz, S. Aebi, and K. Lühlemann Low level resistance to rifampicin in Streptococcus:pneumoniae Antimicrob. Agents Chemother. 47 2003 863 868
19. R. Jones, C.M. Rubino, S.M. Bhavnani, and P.G. Ambrose Worlwide antimicrobial susceptibility patterns and pharmacodynamic comparaisons of gatifloxacin, and levofloxacin against Streptococcus:pneumoniae: report for the antimicrobial rate epidemiology study team Antimicro. Agents Chemother. 47 2003 292 296
20. M.E. Klepser, E.J. Ernst, C.R. Petzold, P. Rhomberg, and G.V. Doern Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model Antimicrob. Agents Chemother. 45 2001 673 678
21. P.L. Ho, T.L. Que, D.N.C. Tsang, T.K. Ng, K.H. Chow, and W.H. Seto Emergence of fluoroquinolones resistance among multiply resistant strains of Streptococcus:pneumoniae in Hong Kong Antimicrob. Agents Chemother. 43 1999 1310 1313
22. D.K. Chen, A. McGeer, and J.C. Azavedo De Low. Decreased susceptibility of Streptococcus:pneumoniae to fluoroquinolones in Canada. Canadian bacterial surveillance network N. Engl. J. Med. 341 1999 233 239